169 related articles for article (PubMed ID: 34409919)
1. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review.
Hassoun HK; Al-Mahadawi A; Sheaheed NM; Sami SM; Jamal A; Allebban Z
Neurol Res; 2022 Jan; 44(1):14-23. PubMed ID: 34409919
[TBL] [Abstract][Full Text] [Related]
2. A CLINICO-EPIDEMIOLOGICAL STUDY OF MULTIPLE SCLEROSIS IN MOSUL CITY, IRAQ.
Taher Y; Ahmed M; Majdal H
Georgian Med News; 2023; (340-341):47-52. PubMed ID: 37805872
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?
Al-Araji A; Mohammed AI
J Neurol Sci; 2005 Jul; 234(1-2):67-71. PubMed ID: 15946690
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological study of multiple sclerosis in La Rioja.
Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.
Zakaria M; Zamzam DA; Abdel Hafeez MA; Swelam MS; Khater SS; Fahmy MF; Abdel Hady A; Fouad MM; Abdel Nasser A; Aref H; Gadallah M
Mult Scler Relat Disord; 2016 Nov; 10():30-35. PubMed ID: 27919495
[TBL] [Abstract][Full Text] [Related]
9. Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis.
Mayo CD; Lacey C; Gawryluk JR;
Mult Scler Relat Disord; 2021 Jun; 51():102884. PubMed ID: 33799287
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological study of multiple sclerosis in the Illawarra region.
Dal SR; Elphick TL; Fuller K
Intern Med J; 2023 Jun; 53(6):1010-1017. PubMed ID: 35112760
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and incidence of multiple sclerosis in Panama (2000-2005).
Gracia F; Castillo LC; Benzadón A; Larreategui M; Villareal F; Triana E; Arango AC; Lee D; Pascale JM; Gomez E; Armien B
Neuroepidemiology; 2009; 32(4):287-93. PubMed ID: 19246933
[TBL] [Abstract][Full Text] [Related]
12. Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients?
Hasan ZN
Neurosciences (Riyadh); 2011 Jul; 16(3):233-6. PubMed ID: 21677613
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador.
Sloka JS; Pryse-Phillips WE; Stefanelli M
Can J Neurol Sci; 2005 Feb; 32(1):37-42. PubMed ID: 15825544
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
Ohlmeier C; Gothe H; Haas J; Osowski U; Weinhold C; Blauwitz S; Schmedt N; Galetzka W; Berkemeier F; Tackenberg B; Stangel M
PLoS One; 2020; 15(5):e0231846. PubMed ID: 32357176
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002.
Tanaka K; Kujuro Y; Suzuki S; Tanahashi N; Hamada J; Nogawa S; Suzuki N
Intern Med; 2005 Jun; 44(6):560-6. PubMed ID: 16020880
[TBL] [Abstract][Full Text] [Related]
16. Time interval between disease onset and MS diagnosis during the last decades in Latin America.
Rojas JI; Carnero Contentti E; Henestroza P; Giachello S; Correale J
Mult Scler Relat Disord; 2021 Feb; 48():102672. PubMed ID: 33338946
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
18. Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report.
Zahoor I; Asimi R; Haq E; Yousuf Wani I
Mult Scler Relat Disord; 2017 Apr; 13():103-106. PubMed ID: 28427689
[TBL] [Abstract][Full Text] [Related]
19. Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study.
Habbestad A; Willumsen JS; Aarseth JH; Grytten N; Midgard R; Wergeland S; Myhr KM; Torkildsen Ø
J Neurol; 2024 Apr; 271(4):1610-1617. PubMed ID: 38097800
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Optic Neuritis among Omani Patients with Multiple Sclerosis at the Sultan Qaboos University Hospital, Muscat, Oman.
Alkharusi F; Sabt B; Al-Mujaini AS
Sultan Qaboos Univ Med J; 2023 Nov; 23(4):472-478. PubMed ID: 38090249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
